Silencing of multi-copy hpv16 by viral self-methylation and chromatin occlusion: A model for epigenetic virus-host interaction

Human Molecular Genetics

Volumn 21, Issue 8, 2012, Pages 1693-1705

  Arce, Johanna De Castro ^a   Göckel krzikalla, Elke ^a   Rösl, Frank ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HETEROCHROMATIN; HUMAN PAPILLOMAVIRUS TYPE 16; LONG TERM SURVIVAL; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; UTERINE CERVIX CARCINOMA; VIRUS CELL INTERACTION; VIRUS GENOME;

CELL LINE, TUMOR; CHROMATIN; DNA METHYLATION; DNA, VIRAL; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GENOME, VIRAL; HISTONES; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84859219959     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr604     Document Type: Article

References (70)

1. Michels, K.B. and zur Hausen, H. (2009) HPV vaccine for all. Lancet, 374, 268-270.
2. Thierry, F. (2009) Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology, 384, 375-379.
3. Sousa, R., Dostatni, N. and Yaniv, M. (1990) Control of papillomavirus gene expression. Biochim. Biophys. Acta, 1032, 19-37.
4. Pett, M. and Coleman, N. (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J. Pathol., 212, 356-367.
5. Rosl, F., Westphal, E.M. and zur Hausen, H. (1989) Chromatin structure and transcriptional regulation of human papillomavirus type 18 DNA in HeLa cells. Mol. Carcinog., 2, 72-80.
6. Jeon, S. and Lambert, P.F. (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl Acad. Sci. USA, 92, 1654-1658.
7. Bauer-Hofmann, R., Borghouts, C., Auvinen, E., Bourda, E., Rosl, F. and Alonso, A. (1996) Genomic cloning and characterization of the nonoccupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa. Virology, 217, 33-41.
8. Rosl, F., Arab, A., Klevenz, B. and zur Hausen, H. (1993) The effect of DNA methylation on gene regulation of human papillomaviruses. J. Gen. Virol., 74, 791-801.
9. Badal, V., Chuang, L.S., Tan, E.H., Badal, S., Villa, L.L., Wheeler, C.M., Li, B.F. and Bernard, H.U. (2003) CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol., 77, 6227-6234.
10. Kalantari, M., Lee, D., Calleja-Macias, I.E., Lambert, P.F. and Bernard, H.U. (2008) Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology, 374, 292-303.
11. Van Tine, B.A., Kappes, J.C., Banerjee, N.S., Knops, J., Lai, L., Steenbergen, R.D., Meijer, C.L., Snijders, P.J., Chatis, P., Broker, T.R. et al. (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J. Virol., 78, 11172-11186.
12. Rajeevan, M.S., Swan, D.C., Duncan, K., Lee, D.R., Limor, J.R. and Unger, E.R. (2006) Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J. Virol. Methods, 138, 170-176.
13. Kim, K., Garner-Hamrick, P.A., Fisher, C., Lee, D. and Lambert, P.F. (2003) Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol., 77, 12450-12459.
14. Turan, T., Kalantari, M., Calleja-Macias, I.E., Cubie, H.A., Cuschieri, K., Villa, L.L., Skomedal, H., Barrera-Saldana, H.A. and Bernard, H.U. (2006) Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology, 349, 175-183.
15. Kalantari, M., Chase, D.M., Tewari, K.S. and Bernard, H.U. (2010) Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. J. Med. Virol., 82, 311-320.
16. Pett, M.R., Herdman, M.T., Palmer, R.D., Yeo, G.S., Shivji, M.K., Stanley, M.A. and Coleman, N. (2006) Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl Acad. Sci. USA, 103, 3822-3827.
17. Gray, E., Pett, M.R., Ward, D., Winder, D.M., Stanley, M.A., Roberts, I., Scarpini, C.G. and Coleman, N. (2010) In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res., 70, 4081-4091.
18. Fernandez, A.F., Rosales, C., Lopez-Nieva, P., Grana, O., Ballestar, E., Ropero, S., Espada, J., Melo, S.A., Lujambio, A., Fraga, M.F. et al. (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res., 19, 438-451.
19. Garrick, D., Fiering, S., Martin, D.I. and Whitelaw, E. (1998) Repeat-induced gene silencing in mammals. Nat. Genet., 18, 56-59.
20. Mincheva, A., Gissmann, L. and zur Hausen, H. (1987) Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med. Microbiol. Immunol., 176, 245-256.
21. Van Tine, B.A., Knops, J., Broker, T.R., Chow, L.T. and Moen, P.T. Jr (2001) In situ analysis of the transcriptional activity of integrated viral DNA using tyramide-FISH. Dev. Biol. (Basel), 106, 381-385.
22. Baker, C.C., Phelps, W.C., Lindgren, V., Braun, M.J., Gonda, M.A. and Howley, P.M. (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol., 61, 962-971.
23. You, J.S., Kang, J.K., Lee, E.K., Lee, J.C., Lee, S.H., Jeon, Y.J., Koh, D.H., Ahn, S.H., Seo, D.W., Lee, H.Y. et al. (2008) Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells. Oncogene, 27, 1376-1386.
24. Giresi, P.G., Kim, J., McDaniell, R.M., Iyer, V.R. and Lieb, J.D. (2007) FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res., 17, 877-885.
25. Lin, J.C., Jeong, S., Liang, G., Takai, D., Fatemi, M., Tsai, Y.C., Egger, G., Gal-Yam, E.N. and Jones, P.A. (2007) Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell, 12, 432-444.
26. De-Castro Arce, J., Gockel-Krzikalla, E. and Rosl, F. (2007) Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region. J. Biol. Chem., 282, 28520-28529.
27. Ponts, N., Harris, E.Y., Prudhomme, J., Wick, I., Eckhardt-Ludka, C., Hicks, G.R., Hardiman, G., Lonardi, S. and Le Roch, K.G. (2010) Nucleosome landscape and control of transcription in the human malaria parasite. Genome Res., 20, 228-238.
28. Kondo, Y., Shen, L., Cheng, A.S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B. et al. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet., 40, 741-750.
29. Hiragami-Hamada, K., Xie, S.Q., Saveliev, A., Uribe-Lewis, S., Pombo, A. and Festenstein, R. (2009) The molecular basis for stability of heterochromatin-mediated silencing in mammals. Epigenetics Chromatin, 2, 14.
30. Schotta, G., Lachner, M., Sarma, K., Ebert, A., Sengupta, R., Reuter, G., Reinberg, D. and Jenuwein, T. (2004) A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev., 18, 1251-1262.
31. Loyola, A. and Almouzni, G. (2007) Marking histone H3 variants: how, when and why? Trends Biochem. Sci., 32, 425-433.
32. Jin, C. and Felsenfeld, G. (2007) Nucleosome stability mediated by histone variants H3.3 and H2A.Z. Genes Dev., 21, 1519-1529.
33. Nagpal, S., Zelent, A. and Chambon, P. (1992) RAR-beta 4, a retinoic acid receptor isoform is generated from RAR-beta 2 by alternative splicing and usage of a CUG initiator codon. Proc. Natl Acad. Sci. USA, 89, 2718-2722.
34. Youssef, E.M., Estecio, M.R. and Issa, J.P. (2004) Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer. Cancer Biol. Ther., 3, 82-86.
35. Lee, J.H., Gaetz, J., Bugarija, B., Fernandes, C.J., Snyder, G.E., Bush, E.C. and Lahn, B.T. (2009) Chromatin analysis of occluded genes. Hum. Mol. Genet., 18, 2567-2574.
36. Han, L., Lin, I.G. and Hsieh, C.L. (2001) Protein binding protects sites on stable episomes and in the chromosome from de novo methylation. Mol. Cell. Biol., 21, 3416-3424.
37. Dowhanick, J.J., McBride, A.A. and Howley, P.M. (1995) Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol., 69, 7791-7799.
38. Shirasawa, H., Jin, M.H., Shimizu, K., Akutsu, N., Shino, Y. and Simizu, B. (1994) Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16. Virology, 203, 36-42.
39. Desaintes, C., Hallez, S., Van Alphen, P. and Burny, A. (1992) Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol., 66, 325-333.
40. Burgers, W.A., Blanchon, L., Pradhan, S., de Launoit, Y., Kouzarides, T. and Fuks, F. (2007) Viral oncoproteins target the DNA methyltransferases. Oncogene, 26, 1650-1655.
41. Kusumoto-Matsuo, R., Kanda, T. and Kukimoto, I. (2011) Rolling circle replication of human papillomavirus type 16 DNA in epithelial cell extracts. Genes Cells, 16, 23-33.
42. Doerfler, W. (2008) In pursuit of the first recognized epigenetic signal-DNA methylation: a 1976 to 2008 synopsis. Epigenetics, 3, 125-133.
43. Andeweg, A.C., Haagmans, B.L. and Osterhaus, A.D. (2008) Virogenomics: the virus-host interaction revisited. Curr. Opin. Microbiol., 11, 461-466.
44. Bodily, J. and Laimins, L.A. (2011) Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol., 19, 33-39.
45. Navratil, V., de Chassey, B., Combe, C.R. and Lotteau, V. (2011) When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases. BMC Syst. Biol., 5, 13.
46. Au Yeung, C.L., Tsang, W.P., Tsang, T.Y., Co, N.N., Yau, P.L. and Kwok, T.T. (2010) HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol. Rep., 24, 1599-1604.
47. Longworth, M.S. and Laimins, L.A. (2004) The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J. Virol., 78, 3533-3541.
48. Thomas, M.C. and Chiang, C.M. (2005) E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol. Cell, 17, 251-264.
49. Braunstein, T.H., Madsen, B.S., Gavnholt, B., Rosenstierne, M.W., Johnsen, C.K. and Norrild, B. (1999) Identification of a new promoter in the early region of the human papillomavirus type 16 genome. J. Gen. Virol., 80, 3241-3250.
50. Grassmann, K., Rapp, B., Maschek, H., Petry, K.U. and Iftner, T. (1996) Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol., 70, 2339-2349.
51. Rincon-Orozco, B., Halec, G., Rosenberger, S., Muschik, D., Nindl, I., Bachmann, A., Ritter, T.M., Dondog, B., Ly, R., Bosch, F.X. et al. (2009) Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells. Cancer Res., 69, 8718-8725.
52. Grunau, C., Clark, S.J. and Rosenthal, A. (2001) Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res., 29, E65-E65.
53. Callinan, P.A. and Feinberg, A.P. (2006) The emerging science of epigenomics. Hum. Mol. Genet., 15(Spec no. 1), R95-R101.
54. Bernstein, B.E., Meissner, A. and Lander, E.S. (2007) The mammalian epigenome. Cell, 128, 669-681.
55. Chen, W.Y., Bailey, E.C., McCune, S.L., Dong, J.Y. and Townes, T.M. (1997) Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl Acad. Sci. USA, 94, 5798-5803.
56. Fuks, F. (2005) DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev., 15, 490-495.
57. Si, J., Boumber, Y.A., Shu, J., Qin, T., Ahmed, S., He, R., Jelinek, J. and Issa, J.P. (2010) Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res., 70, 6968-6977.
58. Lee, J.H., Bugarija, B., Millan, E.J., Walton, N.M., Gaetz, J., Fernandes, C.J., Yu, W.H., Mekel-Bobrov, N., Vallender, T.W., Snyder, G.E. et al. (2009) Systematic identification of cis-silenced genes by trans complementation. Hum. Mol. Genet., 18, 835-846.
59. Jin, C. and Felsenfeld, G. (2006) Distribution of histone H3.3 in hematopoietic cell lineages. Proc. Natl Acad. Sci. USA, 103, 574-579.
60. Thain, A., Jenkins, O., Clarke, A.R. and Gaston, K. (1996) CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol., 70, 7233-7235.
61. Turker, M.S. (2002) Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene, 21, 5388-5393.
62. Lahn, B.T. (2010) The occlusis model of cell fate restriction. Bioessays, 33, 13-20.
63. von Knebel Doeberitz, M., Gissmann, L. and zur Hausen, H. (1990) Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression. Cancer Res., 50, 3730-3736.
64. von Knebel Doeberitz, M., Oltersdorf, T., Schwarz, E. and Gissmann, L. (1988) Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res., 48, 3780-3786.
65. Gebhard, C., Benner, C., Ehrich, M., Schwarzfischer, L., Schilling, E., Klug, M., Dietmaier, W., Thiede, C., Holler, E., Andreesen, R. et al. (2010) General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res., 70, 1398-1407.
66. Xue, Y., Bellanger, S., Zhang, W., Lim, D., Low, J., Lunny, D. and Thierry, F. (2010) HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res., 70, 5316-5325.
67. Vinokurova, S. and von Knebel Doeberitz, M. (2011) Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One, 6, e24451.
68. De-Castro Arce, J., Soto, U., van Riggelen, J., Schwarz, E., Hausen, H.Z. and Rosl, F. (2004) Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cells. J. Biol. Chem., 279, 45408-45416.
69. Giresi, P.G. and Lieb, J.D. (2009) Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods, 48, 233-239.
70. Schneider, G., Saur, D., Siveke, J.T., Fritsch, R., Greten, F.R. and Schmid, R.M. (2006) IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. EMBO J., 25, 3801-3812.